The Medicines (Products Other Than Veterinary Drugs) (General Sale List) Amendment Order 1999

Made: 16th March 1999

Coming into force: 31st March 1999

The Secretaries of State concerned with health in England, in Wales and in Scotland respectively and the Department of Health and Social Services for Northern Ireland, acting jointly, in exercise of the powers conferred upon them by sections 51 and 129(4) of the Medicines Act 1968¹ or, as the case may be, those conferred by those provisions and now vested in them², and of all other powers enabling them in that behalf, after consulting such organisations as appear to them to be representative of interests likely to be substantially affected by this Order pursuant to section 129(6) of that Act and after consulting and taking into account the advice of the Medicines Commission pursuant to section 129(7) of that Act, hereby make the following Order:

Citation, commencement and interpretation

1

• (1) This Order may be cited as the Medicines (Products Other Than Veterinary Drugs) (General Sale List) Amendment Order 1999 and shall come into force on 31st March 1999.

• (2) In this Order, “the principal Order” means the Medicines (Products Other Than Veterinary Drugs) (General Sale List) Order 1984³.

• (3) In this Order, a reference to a numbered column in Table A, unless otherwise indicated, is a reference to the column bearing that number in Table A of the specified Schedule to the principal Order.

Amendment of Schedule 1 to the principal Order

2

• (1) Table A (internal or external use) of Schedule 1 to the principal Order (which specifies the class of medicinal products, other than products the subject of a product licence of right, on general sale by virtue of article 2(a) of the principal Order) is amended as follows–

• (a) there is deleted in column 1 the entry “Methionine, DL except when combined with Paracetamol”⁴; and

• (b) there is inserted in column 1, at the appropriate point in the alphabetical order of the entries as they appear in that column, the entry set out in column 1 of the Schedule to this Order, and against that entry there is inserted in columns 2 and 3 the corresponding text in columns 2 and 3 of the Schedule to this Order.

Amendment of Schedule 2 to the principal Order

3

In Table A (internal or external use) of Schedule 2 to the principal Order (which specifies the class of medicinal products, the subject of a product licence of right, on general sale by virtue of article 2(b) of the principal Order) there is deleted in column 1 the entry “Methionine”.

SCHEDULE — ENTRY INSERTED IN TABLE A OF SCHEDULE 1 TO THE PRINCIPAL ORDER (INTERNAL OR EXTERNAL USE)

Signed

Signed by authority of the Secretary of State for Health

Hayman — Parliamentary Under Secretary of State, — Department of Health — 12th 1999

Jon Owen Jones — Parliamentary Under Secretary of State, Welsh Office — 16th March 1999

Sam Galbraith — Parliamentary Under Secretary of State, The Scottish Office — 15th March 1999

Sealed with the Official Seal of the Department of Health and Social Services for Northern Ireland on

D. C. Gowdy — Permanent Secretary — 5th March 1999

Explanatory note

(This note is not part of the Order)

This Order further amends the Medicines (Products Other Than Veterinary Drugs) (General Sale List) Order 1984 (“the principal Order”) which specifies classes of medicinal products which can with reasonable safety be sold or supplied otherwise than by or under the supervision of a pharmacist (the general sale list).

Article 2 amends Schedule 1 to the principal Order (medicinal products, other than products the subject of a product licence of right, on general sale) by deleting the entry in Table A (internal or external use) for Methionine, DL. It also inserts in Table A of Schedule 1 to the principal Order the entry specified in the Schedule to this Order for Nicotine chewing gum. Methionine is deleted from Table A (internal or external use) of Schedule 2 to the principal Order (medicinal products, the subject of a product licence of right, on general sale), by article 3.

An assessment of the cost to business of complying with this Order has been made, copies of which have been placed in the libraries of both Houses of Parliament. Further copies may be obtained from the Department of Health, Medicines Control Agency, Information Centre, Room 1207, Market Towers, 1 Nine Elms Lane, London SW8 5NQ.

Footnotes